Kilitch Drugs (India) Share Price
202.13-3.59 (-1.75%)
+6.92% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Kilitch Drugs (India) Share Price
202.13-3.59 (-1.75%)
+6.92% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Kilitch Drugs (India) Share Price
202.13-3.59 (-1.75%)
+6.92% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Kilitch Drugs (India) Share Price
202.13-3.59 (-1.75%)
+6.92% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Kilitch Drugs (India) Share Price
202.13-3.59 (-1.75%)
+6.92% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Kilitch Drugs (India) Share Price
202.13-3.59 (-1.75%)
+6.92% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Kilitch Drugs (India) Share Price
202.13-3.59 (-1.75%)
+6.92% past 1 Year
News
Jain Resource Raises FY27 Revenue Growth Forecast To 30,40 Percent
Equity
JAINREC
Jyothy Labs reports sharp Q2 EBITDA decline and margin compression
Equity
JYOTHYLAB
Jyothy Labs Reports Q2 Revenue Growth To Rs 760 Crores
Equity
JYOTHYLAB
Jyothy Labs Approves Buyback At Rs 215 Per Share Through Tender Route
Equity
JYOTHYLAB
Jyothy Labs Reports Sharp Year On Year Decline In Q2 Consolidated Profit
Equity
JYOTHYLAB
Redington Reports Higher Q2 EBITDA Despite Slight Margin Compression
Equity
REDINGTON
S&P 500 Futures Recover After Sharp Election Driven Decline
Broader Market
Nasdaq 100 Futures Recover After Sharp Global Risk Off Decline
Broader Market
MOL Reports Strong Second Quarter EBITDA Growth And Margin Expansion
Equity
MOL
GPT Infraprojects Reports Higher Second Quarter EBITDA And Margin
Equity
GPTINFRA
Redington Reports Strong Q2 Growth In Consolidated Profit And Revenue
Equity
REDINGTON
Meghmani Organics Reports Strong Year On Year Growth In Q2 Net Profit
Equity
MOL
Rolex Rings Reports Strong Second Quarter EBITDA Growth And Margin Expansion
Equity
ROLEXRINGS
GPT Infraprojects Reports Lower Consolidated Net Profit In Second Quarter
Equity
GPTINFRA
Rolex Rings reports strong second quarter revenue growth year on year
Equity
ROLEXRINGS
Redtape Q2 EBITDA Rises Sharply With Margin Expansion
Equity
REDTAPE
Rolex Rings Reports Strong Second Quarter Net Profit Growth
Equity
ROLEXRINGS
Redtape Q2 revenue declines marginally year on year to Rs 480 crores
Equity
REDTAPE
JTEKT India Reports Higher Q2 EBITDA Despite Margin Compression
Equity
JTEKTINDIA
Marksans Reports Strong Q2 EBITDA Growth And Margin Expansion
Equity
MARKSANS